Indigo Biosystems
Latest round
- Series B
Last raised
- Jun 2014
Total raised
- $8.5M
Investors
- 1
About Indigo Biosystems
Founded in 2006, Indigo Biosystems operates from Indianapolis, US, and specializes in laboratory automation technology. The company has not undergone any significant pivots or changes in its business strategy and does not have subsidiaries. The CEO and founder, Randall Julian, has a history in entrepreneurship.Indigo BioAutomation specializes in advanced laboratory automation and data analytics solutions, primarily through its flagship products, ASCENT and ARQ. ASCENT is designed for chromatography and mass spectrometry, enhancing workflow efficiency and data insights while ensuring compliance with Quality practices and standard operating procedures (SOPs). ARQ caters to PCR workflows, facilitating streamlined performance and simplifying complex data analysis. The solutions are tailored for clinical and life science laboratories, addressing the challenges of managing vast amounts of data and complex instrumentation.Indigo BioAutomation generates revenue through a Software as a Service (SaaS) model, where clients subscribe to access its advanced software solutions, including ASCENT and ARQ. This subscription-based structure allows laboratories to leverage the full capabilities of Indigo's products from anywhere, enhancing operational efficiency. Clients typically engage in annual contracts, facilitating ongoing access to updates and support. Revenue is derived primarily from B2B transactions with laboratories, clinical facilities, and research institutions that require high-throughput data analysis and automation solutions.Indigo Biosystems is focusing on developing new products to support laboratory workflows and enhance data analytics capabilities; however, specific product launch dates have not been disclosed. The company is also considering geographic expansion into new markets, targeting regions in Europe and Asia by the end of 2025.
Who invested in Indigo Biosystems
1 investor across 1 round
See all investors in Indigo Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 12, 2014
Amount
$8.5M
Investors
Questions about Indigo Biosystems
Who invested in Indigo Biosystems?
Indigo Biosystems has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Indigo Biosystems raised?
Indigo Biosystems has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Indigo Biosystems last raise money?
Indigo Biosystems's most recent round on record is a Series B, in Jun 2014.
What does Indigo Biosystems do?
Founded in 2006, Indigo Biosystems operates from Indianapolis, US, and specializes in laboratory automation technology.
Where is Indigo Biosystems headquartered?
Indigo Biosystems is headquartered in Indianapolis, US.
Which VCs invest in companies like Indigo Biosystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Indigo Biosystems's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Indigo Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.